Gilphex is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Gil Pharmaceutical Corp.. The primary component is Guaifenesin; Phenylephrine Hydrochloride.
| Product ID | 58552-336_e14db3c0-f581-7ae7-e053-2995a90a6896 |
| NDC | 58552-336 |
| Product Type | Human Otc Drug |
| Proprietary Name | Gilphex |
| Generic Name | Guaifenesin, Phenylephrine Hcl |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-05-05 |
| Marketing Category | OTC MONOGRAPH FINAL / |
| Application Number | part341 |
| Labeler Name | Gil Pharmaceutical Corp. |
| Substance Name | GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
| Active Ingredient Strength | 390 mg/1; mg/1 |
| Pharm Classes | Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-05-05 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 58552-336 | Gilphex | Guaifenesin, Phenylephrine HCl |
| 66576-336 | Gilphex | Guaifenesin, Phenylephrine HCl |
| 76864-209 | BACZOL EXPECTORANT | GUAIFENESIN, PHENYLEPHRINE HCl |
| 45737-606 | Biophex | Guaifenesin, Phenylephrine HCl |
| 58552-332 | Giltuss Sinus and Chest Congestion | Guaifenesin, Phenylephrine HCl |
| 0363-0542 | Mucus Relief PE | Guaifenesin, Phenylephrine HCl |
| 68016-686 | Mucus Relief PE | Guaifenesin, Phenylephrine HCl |
| 70000-0141 | Mucus Relief PE Sinus Congestion | Guaifenesin, Phenylephrine HCl |
| 59779-548 | Non-Drying Sinus PE | Guaifenesin, Phenylephrine HCl |
| 21130-927 | Sinus PE | Guaifenesin, Phenylephrine HCl |
| 50844-548 | Sinus Relief PE | Guaifenesin, Phenylephrine HCl |
| 54859-605 | Tusnel Pediatric Drops | Guaifenesin, Phenylephrine HCl |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() GILPHEX 78096487 not registered Dead/Abandoned |
Gil Pharmaceutical Corp. 2001-12-04 |